What we're about
Advancing prediction, prevention, and precision therapy for patients with rheumatic diseasesWho we are
Over 200 researchers spanning the basic, clinical, and analytical sciencesHow we help
World-class core facilities and investigator support to drive groundbreaking research and launch distinctive careersWhy we care
Patients with rheumatic diseases need better tests and personalized treatments so they can live healthier, longer lives
Recent Publications
- Association between systemic lupus erythematosus and myasthenia gravis: A population-based National Study November 10, 2023
- Ancestry-based differences in the immune phenotype are associated with lupus activity August 22, 2023
- Mortality risk factors in primary Sjögren syndrome: a real-world, retrospective, cohort study July 17, 2023
- Autoantibodies identify primary Sjögren's syndrome in patients lacking serum IgG specific for Ro/SS-A and La/SS-B May 5, 2023
- Immune profiling in Puerto Rican injection drug users with and without HIV-1 infection April 12, 2023
- Characterising the autoantibody repertoire in systemic sclerosis following myeloablative haematopoietic stem cell transplantation January 18, 2023
- Genetic load in incomplete lupus erythematosus January 4, 2023